Related Experiment Video
Updated: May 6, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation
Hanene Ali-Boucetta1, Kostas Kostarelos
1Pharmacy, Pharmacology and Therapeutics, School of Clinical and Experimental Medicine, Medical School, University of Birmingham, Birmingham B15 2TT, UK.
Abstract:
Carbon nanotubes (CNT) are increasingly being investigated for their use in biomedical applications and nanomedicine. An emergent need for the understanding of their in vivo biodistribution and pharmacokinetics is therefore needed to establish the essential properties and criteria for their further development as targeted CNT delivery systems to specific tissues for diagnostics and therapeutic purposes. Until their biodistribution and toxicoketic profiles are fully understood, their translation into the clinic will be hindered. This review will highlight the important factors affecting the biodistribution and pharmacokinetic profile of CNT and address their toxicokinetics following systemic, pulmonary and dermal exposure.
Related Concept Videos
Toxicokinetics: Overview
Drug Toxicity: Dose-Dependent Reactions
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Distribution: Tissue Binding
For...
Bioactivation and Tissue Toxicity
Drug Excretion: Pulmonary and Glandular Routes
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...

